Marika Watanabe
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
RUNX1 rearrangement in mature B-cell acute lymphoblastic leukemia with non-L3 morphology.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: October 29, 2023
Irreversible Intrathecal Chemotherapy-induced Myelopathy in a Patient with Diffuse Large B-cell Lymphoma.
Journal: Internal medicine (Tokyo, Japan)
Published: June 28, 2023
Response to mRNA SARS-CoV-2 vaccination evaluated by B-cell receptor repertoire after tixagevimab/cilgavimab administration.
Journal: British journal of haematology
Published: March 22, 2023
Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study.
Journal: Internal medicine (Tokyo, Japan)
Published: February 15, 2023
Safety and Accuracy of Professional Continuous Glucose Monitoring in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Blood cell therapy
Published: December 30, 2022
A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients.
Journal: Vaccines
Published: October 10, 2022
Global longitudinal strain is superior to ejection fraction for long-term follow-up after allogeneic hematopoietic stem cell transplantation.
Journal: EJHaem
Published: August 12, 2022
Biclonal Diffuse Large B-cell Lymphoma Commonly Characterized by Partial Trisomy 18q Involving MALT1 and BCL2.
Journal: Internal medicine (Tokyo, Japan)
Published: June 15, 2022
Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination.
Journal: Vaccines
Published: May 01, 2022
The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation.
Journal: Vaccines
Published: December 28, 2021
Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody.
Journal: International journal of hematology
Published: September 06, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026